ArticleDiscover oncology2024

Transarterial chemoembolization with/without immune checkpoint inhibitors plus tyrosine kinase inhibitors for unresectable hepatocellular carcinoma: a single center, propensity score matching real-world study.

Guosheng Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.